Joseph E. Payne - Nov 23, 2022 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
President and CEO, Director
Signature
/s/ Ilan Katz, attorney-in-fact
Stock symbol
ARCT
Transactions as of
Nov 23, 2022
Transactions value $
$82,550
Form type
4
Date filed
11/28/2022, 03:07 PM
Previous filing
Jun 23, 2022
Next filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARCT Common Stock Purchase $82.6K +5K +0.34% $16.51 1.48M Nov 23, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the purchase price paid by the Reporting Person for the shares of common stock, $0.001 par value per share, of the Registrant, in an open market transaction.